<DOC>
	<DOCNO>NCT02718885</DOCNO>
	<brief_summary>The overall objective study examine change within gut microbiome supplementation inulin effect marker mineral metabolism bone turnover .</brief_summary>
	<brief_title>Gut Microbiome Mediated Effects Inulin Supplementation Mineral Bone Metabolism Hemodialysis Patients</brief_title>
	<detailed_description>In randomize control cross-over study , twenty HD patient ( 10 male/10 female , age 20-80 ) recruit local dialysis clinic Champaign-Urbana , IL . After baseline testing , patient randomize intervention group placebo group ( maltodextrin ) . Patients consume inulin ( females 10g/day , male 15g/day ) maltodextrin ( females 10g/day , male 15g/day ) one month , rest two week ( washout period ) , continue treatment ( either inulin maltodextrin ) another month . Outcomes assessed beginning period month supplementation period .</detailed_description>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Bone Diseases , Endocrine</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Levan</mesh_term>
	<criteria>Receive HD therapy 3 day per week least 3 month Sustained hypercalcemia ( &gt; 3months ) . Previous major gastrointestinal disease diagnosis ( e.g. , inflammatory bowel disease celiac disease ) . Antibiotic treatment &lt; 2 week prior start study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>inulin-type fructans</keyword>
	<keyword>hemodialysis</keyword>
	<keyword>gut microbiome</keyword>
	<keyword>mineral bone disorder</keyword>
</DOC>